| ns0:DescribedValueSet  
|   : ID^2.16.840.1.113883.3.526.3.1212
|   : displayName^Intolerance to ACE inhibitor or ARB
|   : version^20121025
|  | ns0:ConceptList  
                Code    System         Description
           293500009  SNOMEDCT  Angiotensin-converting-enzyme inhibitor adverse reaction (disorder)
           293501008  SNOMEDCT  Captopril adverse reaction (disorder)
           293502001  SNOMEDCT  Lisinopril adverse reaction (disorder)
           293503006  SNOMEDCT  Quinapril adverse reaction (disorder)
           293504000  SNOMEDCT  Ramipril adverse reaction (disorder)
           293505004  SNOMEDCT  Cilazapril adverse reaction (disorder)
           293506003  SNOMEDCT  Trandolapril adverse reaction (disorder)
           293507007  SNOMEDCT  Enalapril adverse reaction (disorder)
           293508002  SNOMEDCT  Fosinopril adverse reaction (disorder)
           293509005  SNOMEDCT  Perindopril adverse reaction (disorder)
           293513003  SNOMEDCT  Losartan adverse reaction (disorder)
           371627004  SNOMEDCT  Angiotensin converting enzyme inhibitor-aggravated angioedema (disorder)
           407564000  SNOMEDCT  Angiotensin converting enzyme inhibitor not tolerated (situation)
           407565004  SNOMEDCT  Angiotensin II receptor antagonist not tolerated (situation)
           407590002  SNOMEDCT  Angiotensin II receptor antagonist adverse reaction (disorder)
           422593004  SNOMEDCT  Acute renal failure due to angiotensin-converting-enzyme inhibitor (disorder)
|  | ns0:Source American Medical Association-convened Physician Consortium for Performance Improvement(R)
|  | ns0:Definition (2.16.840.1.113883.3.526.2.1257:Intolerance to ACE inhibitor or ARB)
|  | ns0:Type Grouping
|  | ns0:Binding Static
|  | ns0:Status Active
|  | ns0:RevisionDate 2012-10-25
--------------------------------------------------------------
CATEGORY: Condition/Diagnosis/Problem
CMS eMeasure ID: CMS135v1
Endorsed By: National Quality Forum
GUID: 430ffc53-4122-4421-88cc-2edd8117bb3c
Meaningful Use Measures: CY 2014 EP
Measure Developer: American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)
Measure Steward: American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)
Measure Type: PROCESS
NQF Number: 0081
SHEETNAME: HF_ACE_ARB_LVSD
eMeasure Copyright: Copyright 2012 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.
eMeasure Description: Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 m
eMeasure Identifier: 135
eMeasure Status: Complete
eMeasure Title: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
eMeasure Version number: 1
